Skip to main content

Find Clinical Trials

Home
Conditions
Empagliflozin in Post AKI Stage 2-3

Clinical trial condition

Empagliflozin in Post AKI Stage 2-3

Explore clinical trials studying Empagliflozin in Post AKI Stage 2-3. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Empagliflozin in Post AKI Stage 2-3 trial results

Active, Not Recruiting

The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors

NCT05360615

Conditions: Empagliflozin in Post AKI Stage 2-3
Locations: Central Chest Institute of Thailand Nonthaburi, Mueang Nonthaburi District, Thailand

View Trial Details